Abstract:CRISPR systems have been proven as versatile tools for site-specific genome engineering in mammalian species. During the gene editing processes, these RNA-guide nucleases introduce DNA double strand breaks (DSBs), in which non-homologous DNA end joining (NHEJ) dominates the DNA repair pathway, limiting the efficiency of homology-directed repair (HDR), the alternative pathway essential for precise gene targeting. Multiple approaches have been developed to enhance HDR, including chemical compound or RNA interference-mediated inhibition of NHEJ factors, small molecule activation of HDR enzymes, or cell cycle timed delivery of CRISPR complex. However, these approaches face multiple challenges, yet have moderate or variable effects. Here we developed a new approach that programs both NHEJ and HDR pathways with CRISPR activation and interference (CRISPRa/i) to achieve significantly enhanced HDR efficiency of CRISPR-mediated gene editing. The manipulation of NHEJ and HDR pathway components, such as CtIP, CDK1, KU70, KU80, and LIG4, was mediated by catalytically dead guide RNAs (dgRNAs), thus relying on only a single catalytically active Cas9 to perform both CRISPRa/i and precise gene editing. While reprogramming of most DNA repair factors or their combinations tested enhanced HDR efficiency, simultaneously activating CDK1 and repressing KU80 has the strongest effect with increased HDR rate upto an order of magnitude. Doxycycline-induced dgRNA-based CRISPRa/i programming of DNA repair enzymes, as well as viral packaging enabled flexible and tunable HDR enhancement for broader applicability in mammalian cells. Our study provides an effective, flexible, and potentially safer strategy to enhance precise genome modifications, which might broadly impact human gene editing and therapy.

Genome editing in mammals using CRISPR type I-D nuclease

Genome editing in mammalian cells using the CRISPR type I-D nuclease

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Versatile and efficient mammalian genome editing with Type I-C CRISPR System of Desulfovibrio vulgaris

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

Deaminase-mediated multiplex genome editing in Escherichia coli

Genome engineering using the CRISPR-Cas9 system

CRISPR-Cas systems for editing, regulating and targeting genomes

Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems

DNA targeting by compact Cas9d and its resurrected ancestor

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes

CRISPR/Cas9 Systems: The Next Generation Gene Targeted Editing Tool

A Targeted and Tuneable DNA Damage Tool Using CRISPR/Cas9

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems

DNA Fragment Editing of Genomes by CRISPR/Cas9.

Structure and genome editing of type I-B CRISPR-Cas